Related Experiment Video
Updated: Oct 26, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Autoimmune Encephalitis Resembling Dementia Syndromes.
Anna E M Bastiaansen1, Robin W van Steenhoven1, Marienke A A M de Bruijn1
1From the Department of Neurology (A.E.M.B., R.W.v.S., Y.S.C., M.H.v.C.-H., P.A.E.S.S., J.M.d.V., M.J.T.), Erasmus MC University Medical Center, Rotterdam; Department of Neurology, VU University Medical Center, Amsterdam (R.W.v.S.); Department of Neurology (M.A.A.M.d.B.), Elisabeth Tweesteden Medical Center, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Honours Student Bachelor Biomedical Sciences (M.M.N.), University Utrecht; Department of Neurology and Laboratory Medicine (M.M.V.), Donders Institute for Brain Cognition and Behavior, Radboud University Medical Center, Nijmegen; Department of Immunology (M.W.J.S.), Erasmus MC University Medical Center, Rotterdam; and Alzheimer Center Erasmus MC (F.J.d.J.), Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Autoimmune encephalitis (AIE) frequently mimics dementia in older adults, presenting with rapid cognitive decline and subtle seizures. Early diagnosis and immunotherapy are crucial as most patients with AIE show improvement.
Area of Science:
- Neurology
- Immunology
- Neuroscience
Background:
- Autoimmune encephalitis (AIE) can present with symptoms overlapping neurodegenerative dementia syndromes.
- Patients with AIE do not always exhibit classic encephalitis symptoms, leading to diagnostic challenges.
Purpose of the Study:
- To evaluate the frequency of AIE mimicking dementia in middle-aged and older patients.
- To identify red flags for AIE in this demographic to improve early diagnosis.
Main Methods:
- Nationwide observational cohort study.
- Included patients (age ≥45 years) with anti-LGI1, anti-NMDAR, anti-GABABR, or anti-CASPR2 encephalitis meeting dementia criteria and lacking early prominent seizures.
- Analyzed clinical presentation, diagnostic findings, and treatment outcomes.
Main Results:
- 38% of 175 older AIE patients (≥45 years) met dementia criteria without early seizures.
- Rapid cognitive decline (76%) and subtle seizures (27%) were observed; 25% lacked typical inflammatory brain MRI or CSF findings.
- Abnormal CSF biomarkers, including 14-3-3, were frequent (61% tested).
Conclusions:
- Key red flags for AIE in suspected dementia cases include rapidly progressive cognitive decline, subtle seizures, and atypical ancillary test results.
- Physicians must consider AIE even without typical inflammatory signs, as biomarkers for dementia can be abnormal.
- Prompt diagnosis and immunotherapy significantly benefit most AIE patients.
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Parkinson's Disease: Overview
Alzheimer's Disease: Treatment
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...

